Advertisement
Screener

KYMERA THERAPEUTICS, INC. (KYMR) Other

KYMERA THERAPEUTICS, INC. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-02-26: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.0001 per share · KYMR · The Nasdaq Global Market.
  • 2025-02-27: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.0001 per share · KYMR · The Nasdaq Global Market.
  • 2024-02-22: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.0001 per share · KYMR · The Nasdaq Global Market.
  • 2023-02-23: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.0001 per share · KYMR · The Nasdaq Global Market.
FiledFormItemAs filed
2026-02-2610-KStock registered under Section 12(b)Common Stock, par value $0.0001 per share · KYMR · The Nasdaq Global Market
2025-02-2710-KStock registered under Section 12(b)Common Stock, par value $0.0001 per share · KYMR · The Nasdaq Global Market
2024-02-2210-KStock registered under Section 12(b)Common Stock, par value $0.0001 per share · KYMR · The Nasdaq Global Market
2023-02-2310-KStock registered under Section 12(b)Common Stock, par value $0.0001 per share · KYMR · The Nasdaq Global Market
2022-02-2410-KStock registered under Section 12(b)Common Stock, par value $0.0001 per share · KYMR · The Nasdaq Global Market
2021-11-1010-QSmaller reporting companyYes
2021-11-1010-QEmerging growth companyYes
2021-11-1010-QCurrent in its reportingNo
2021-08-0610-QSmaller reporting companyYes
2021-08-0610-QEmerging growth companyYes
2021-08-0610-QCurrent in its reportingNo
2021-05-0610-QSmaller reporting companyYes
2021-05-0610-QEmerging growth companyYes
2021-05-0610-QCurrent in its reportingNo
2021-03-1110-KSmaller reporting companyYes
2021-03-1110-KEmerging growth companyYes
2021-03-1110-KWell-known seasoned issuerNo
2020-11-0510-QSmaller reporting companyYes
2020-11-0510-QEmerging growth companyYes
2020-11-0510-QCurrent in its reportingNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
REPLIGEN CORP (RGEN)United States$10.755B185.31
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
BIO-TECHNE Corp (TECH)United States$11.379B74.68
Twist Bioscience Corp (TWST)United States$11.540B-47.21
Immunovant, Inc. (IMVT)United States$7.028B-14.78
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
CG Oncology, Inc. (CGON)United States$6.095B-27.95
Scholar Rock Holding Corp (SRRK)United States$5.920B-16.37